Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Horizon Discovery and Rutgers University form exclusive partnership to develop next generation novel gene editing technology

Tuesday, January 29, 2019

Horizon Discovery Group plc a global leader in gene editing and gene modulation technologies today announces that it has entered into an exclusive strategic partnership with Rutgers The State University of New Jersey US to develop and commercialise a...

Olon SpA acquires Capua BioServices SpA

Monday, January 28, 2019

Olon SpA a global leader in pharmaceutical active substances API a company dedicated to manufacturing and development outsourcing CDMO and a supplier of generics today announced the acquisition of Capua BioServices SpA a global supplier of CDMO serv...

Q BioMed Technology Partner Mannin Research Enters Into Collaboration With McMaster University for Glaucoma Drug Candidate MAN-01

Monday, January 28, 2019

Q BioMed Inc a biotechnology acceleration company announced today that its technology partner Mannin Research has initiated a collaboration with McMaster University of Ontario Canada The collaboration is focused on ophthalmic drug delivery and formul...

Origenis GmbH Announces Global License and Collaboration Agreement with Expansion Therapeutics for Novel Therapies Targeting RNA-mediated Diseases

Friday, January 25, 2019

Origenis announced today it has entered into a global license and collaboration agreement with Expansion Therapeutics to research and discover small molecule compounds targeting RNAmediated diseases As part of the agreement the companies will initiat...

BioNTech to Acquire Antibody Generation Unit of MAB Discovery

Friday, January 25, 2019

BioNTech AG a rapidly growing biotechnology company developing precise and individualized immunotherapies for the treatment of cancer and the prevention of infectious diseases and MAB Discovery GmbH a unique player in the generation and development o...

Philogen Announces Drug Discovery Collaboration With Johnson & Johnson Innovation

Thursday, January 24, 2019

Philogen SpA a privatelyowned biotechnology company today announced through its whollyowned Swiss subsidiary Philochem AG a collaboration agreement with Janssen Biotech Inc one of the Janssen Pharmaceutical Companies of Johnson Johnson to discover n...

B-MoGen Biotechnologies and CytoSen Therapeutics partner on research collaboration to develop next generation Natural Killer Cells

Thursday, January 24, 2019

BMoGen Biotechnologies Inc and CytoSen Therapeutics announced today a research collaboration to develop the next generation of genemodified Natural Killer Cell NK therapies BMoGen will utilize its expertise in genetic design and its patented nonviral...

Ferring, Rebiotix and Karolinska Institutet Extend Collaboration to Research Next Generation of Microbiome Treatments

Wednesday, January 23, 2019

Ferring Pharmaceuticals and Karolinska Institutet announced today a fiveyear extension of their collaboration to explore the potential of the human microbiome in reproductive medicine and womens health and gastroenterology The collaboration brings to...

Gamida Cell and Be The Match BioTherapies® Announce Strategic Collaboration

Wednesday, January 23, 2019

Gamida Cell Ltd a leading cellular and immune therapeutics company and Be The Match BioTherapies a subsidiary of the National Marrow Donor ProgramBe The Match offering integrated platforms and software to manage the collection and delivery of cellula...

Alnylam Pharmaceuticals and Medison Pharma Partner to Commercialize iARN Therapeutics in Israel

Tuesday, January 22, 2019

Alnylam Pharmaceuticals Inc Leader of iARN Therapeutics and Medison Pharma Israels Leading Commercial Partner for Innovative Pharmaceuticals announced today an exclusive agreement to market ONPATTRO the first ever commercialized iARN therapeutic a...